Need Help? Call 1­-866-­796-­7386
« back to stock screener

  XXII stock: 22nd Century Group Inc

Current Rating
Sell

Previous Rating

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$2.76
Market Cap
294.6M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
3.93
P/S
14.89
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-12.5K
FCF
-0.1
Op. Margin
-75.10%
Net Margin
-44.00%
ROE
-17.50%
ROI
-17.60%
ROA
-16.20%
EPS Growth
32.10%
Current Ratio
15.7
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Opiant Pharmaceuticals Inc (OPNT) $16.24 - - 40.1M Strong Buy
Nature's Sunshine Prod. (NATR) $9.35 - 4.30% 180.1M Strong Buy
Kalvista Pharmaceuticals Inc (KALV) $9.29 - - 87.7M Strong Buy
China Pharma Holdings, Inc. (CPHI) $0.25 - - 10M Strong Buy
Pernix Therapeutics Holdings I (PTX) $2.42 - - 29M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More